Chargement en cours...
The Epothilones: New Therapeutic Agents for Castration-Resistant Prostate Cancer
The management of castration-resistant prostate cancer (CRPC) presents a clinical challenge because of limitations in efficacy and durability with currently available therapeutics. The epothilones represent a novel class of anticancer therapy that stabilizes microtubules, causing cell death and tumo...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
AlphaMed Press
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3228074/ https://ncbi.nlm.nih.gov/pubmed/21964003 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2010-0014 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|